DE3576154D1 - 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung. - Google Patents

5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.

Info

Publication number
DE3576154D1
DE3576154D1 DE8585114440T DE3576154T DE3576154D1 DE 3576154 D1 DE3576154 D1 DE 3576154D1 DE 8585114440 T DE8585114440 T DE 8585114440T DE 3576154 T DE3576154 T DE 3576154T DE 3576154 D1 DE3576154 D1 DE 3576154D1
Authority
DE
Germany
Prior art keywords
production
compounds
diazohydroxide
cyanopyridine
basic salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585114440T
Other languages
German (de)
English (en)
Inventor
David C Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Application granted granted Critical
Publication of DE3576154D1 publication Critical patent/DE3576154D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE8585114440T 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung. Expired - Lifetime DE3576154D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use

Publications (1)

Publication Number Publication Date
DE3576154D1 true DE3576154D1 (de) 1990-04-05

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585114440T Expired - Lifetime DE3576154D1 (de) 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.

Country Status (10)

Country Link
US (1) US4636564A (OSRAM)
EP (1) EP0181636B1 (OSRAM)
JP (1) JPS61158967A (OSRAM)
AT (1) ATE50566T1 (OSRAM)
AU (1) AU576914B2 (OSRAM)
CA (1) CA1255654A (OSRAM)
DE (1) DE3576154D1 (OSRAM)
DK (1) DK159847C (OSRAM)
ES (1) ES8700238A1 (OSRAM)
ZA (1) ZA858315B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
ES8700238A1 (es) 1986-10-01
JPH0146511B2 (OSRAM) 1989-10-09
EP0181636A3 (en) 1987-04-01
DK159847B (da) 1990-12-17
DK159847C (da) 1991-05-13
DK514285D0 (da) 1985-11-07
ZA858315B (en) 1986-10-29
AU4983585A (en) 1986-05-22
ES548791A0 (es) 1986-10-01
ATE50566T1 (de) 1990-03-15
CA1255654A (en) 1989-06-13
AU576914B2 (en) 1988-09-08
DK514285A (da) 1986-05-14
EP0181636B1 (en) 1990-02-28
US4636564A (en) 1987-01-13
EP0181636A2 (en) 1986-05-21
JPS61158967A (ja) 1986-07-18

Similar Documents

Publication Publication Date Title
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE59409595D1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
ATE353321T1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
ATE45156T1 (de) Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion.
ATE50566T1 (de) 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.
DE3586879D1 (de) Pyridinderivate und verfahren zu ihrer herstellung.
ATE37369T1 (de) Eine thiazinverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68918597D1 (de) Neues S-Timolol Derivat und Verfahren zu seiner Herstellung.
ATE109144T1 (de) Furylthiazol-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
DE3576155D1 (de) Diazohydroxypyrazinverbindungen, verfahren zu deren herstellung und verwendung.
EP0351795A3 (en) Novel deoxyadenosine compounds and methods of making and using the same
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
PT81078A (de) Aminosaeurederivate verfahren zu ihrer herstellung und pharmazeutische zusamensetzungen
DE69030205D1 (de) Bipolarer Transistor und Verfahren zu dessen Herstellung
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATA247680A (de) Verfahren zur herstellung von -9-hydrazono-6,7,8, 9-tetravaydro-4h-pyrido/1,2-a/ pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren
ATA256387A (de) Isochinolin-derivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zusammensetzungen und deren verwendung
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
ATE97660T1 (de) Pharmakologisch wirksame 3-substituierte 1,5diaryl-pyrazole und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee